Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool.

Drugs & Aging
Benjamin J BasgerRebekah J Moles

Abstract

Evidence-practice gaps, adverse medication-related incidents and unplanned medical admissions to hospital are common in elderly Australians. Many prescribing indicator tools designed to address some of these problems have been reported in the literature, the most common of which is the Beers list of inappropriate medications in the elderly. However, many of these tools are not appropriate for the Australian healthcare environment without modification and validation, and there appears to be a need for a tool based on Australian data. To develop a list of prescribing indicators for elderly (aged >65 years) Australians based on the most frequent medications prescribed to Australians, and the most frequent medical conditions for which elderly Australians consult medical practitioners. The most common reasons for elderly Australians to seek or receive healthcare were cross-referenced with the 50 highest-volume Pharmaceutical Benefits Scheme medications prescribed to Australians in 2006 to develop prescribing indicators in the elderly using Australian medication and medical condition information resources. Forty-eight prescribing indicators were identified, consisting mainly of optimum as well as inappropriate medication choices for ...Continue Reading

References

Oct 1, 1992·Journal of Clinical Epidemiology·J T HanlonJ R Feussner
Mar 1, 1994·Journal of General Internal Medicine·P F NewtonD Maslen
Jan 1, 1997·British Journal of Clinical Pharmacology·C A OborneS H Jackson
Aug 1, 1997·Australian and New Zealand Journal of Public Health·A J Parkes, L C Coper
Dec 23, 1998·Journal of the American Pharmaceutical Association : APhA·N J BrownJ Avorn
Feb 24, 2001·Journal of the American Geriatrics Society·J T HanlonM Weinberger
Jul 18, 2001·Internal Medicine Journal·M ChanJ H Vial
Jul 11, 2002·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·C J MorrisP R Noyce
Jul 12, 2002·Journal of the American Geriatrics Society·Philip D SloaneJoan F Walsh
Jul 5, 2003·The Annals of Pharmacotherapy·Shelly L GrayMichael P Curtis
Aug 5, 2003·Internal Medicine Journal·J E BylesL Parkinson
Aug 13, 2003·Journal of Clinical Pharmacy and Therapeutics·C J Morris, J A Cantrill
Nov 14, 2003·Journal of Managed Care Pharmacy : JMCP·Neil J Mackinnon, Charles D Hepler
Jan 8, 2004·Mayo Clinic Proceedings·Darryl S ChutkaRobert W Hoel
Jan 30, 2004·British Journal of Clinical Pharmacology·P A RoutledgeK W Woodhouse
Apr 14, 2004·Archives of Internal Medicine·Celene M Amabile, Anne P Spencer
May 6, 2004·Annals of Internal Medicine·Takahiro HigashiNeil S Wenger
Jul 3, 2004·BMJ : British Medical Journal·Munir PirmohamedAlasdair M Breckenridge
Oct 16, 2004·Journal of Evaluation in Clinical Practice·Hugh McGavock
Nov 24, 2004·The American Journal of Geriatric Pharmacotherapy·Emily R HajjarKenneth E Schmader
Mar 22, 2005·The Medical Journal of Australia·Christel L BurgessAnthony G Satti
May 21, 2005·Drugs & Aging·Louis MerleJean-Pierre Charmes
Oct 20, 2005·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Mary Patricia Tully, Judith A Cantrill
Apr 6, 2006·The Medical Journal of Australia·Elizabeth E Roughead, Joel Lexchin
Apr 6, 2006·The Medical Journal of Australia·Graeme C MillerLisa Valenti
Oct 27, 2006·Pharmacy World & Science : PWS·Benoît AllenetOrnella Conort
Feb 3, 2007·Pharmacy World & Science : PWS·Michelle A King, Michael S Roberts
Feb 22, 2007·The Annals of Pharmacotherapy·Elda Jano, Rajender R Aparasu
Mar 27, 2007·Journal of Clinical Pharmacy and Therapeutics·P GallagherD O'Mahony
May 31, 2007·Internal Medicine Journal·E E RougheadA L Gilbert
Jun 8, 2007·European Journal of Clinical Pharmacology·Marie-Laure LarocheLouis Merle
Jul 17, 2007·Lancet·Louise MalletAllen Huang
Jul 20, 2007·The Medical Journal of Australia·Mark F Harris, Nicholas A Zwar
Sep 15, 2007·BMJ : British Medical Journal·Bruce GuthrieTom Fahey
Jan 26, 2008·International Journal of Clinical Pharmacology and Therapeutics·P GallagherD O'Mahony
Mar 20, 2008·Age and Ageing·Denis O'Mahony, Paul Francis Gallagher

❮ Previous
Next ❯

Citations

Aug 15, 2012·European Journal of Clinical Pharmacology·J Simon BellSirpa Hartikainen
Sep 11, 2013·European Journal of Clinical Pharmacology·Carole P KaufmannMarkus L Lampert
Jul 12, 2011·International Journal of Clinical Pharmacy·Petra Denig, Flora Haaijer-Ruskamp
Sep 5, 2013·Drugs & Aging·Colin M CurtainGregory M Peterson
Jan 2, 2013·Dementia and Geriatric Cognitive Disorders Extra·Pascalle R BosboomChristopher Beer
May 31, 2012·Drugs & Aging·Marie N O'ConnorDenis O'Mahony
Jul 5, 2013·QJM : Monthly Journal of the Association of Physicians·A PoudelC Mitchell
Nov 21, 2014·BMC Health Services Research·Janine A CooperUNKNOWN (The PROMPT Steering Group)
Dec 3, 2013·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Vera WeingärtnerMatthias Schrappe
Mar 27, 2012·PM & R : the Journal of Injury, Function, and Rehabilitation·Andrew I GellerDale C Strasser
Jan 3, 2012·Journal of the American Medical Directors Association·Fermín García-GollarteAlfonso J Cruz-Jentoft
Oct 23, 2016·Research in Social & Administrative Pharmacy : RSAP·Lisa KouladjianSarah N Hilmer
Aug 25, 2015·International Journal of Clinical Pharmacy·Benjamin J BasgerTimothy F Chen
Aug 21, 2010·Journal of Evaluation in Clinical Practice·Ronald L CastelinoTimothy F Chen
Jul 30, 2011·Journal of the American Geriatrics Society·Maarit S DimitrowSaija N S Leikola
May 5, 2012·The International Journal of Pharmacy Practice·Benjamin J BasgerRebekah J Moles
Jul 13, 2011·The Mount Sinai Journal of Medicine, New York·Manpreet K Boparai, Beatriz Korc-Grodzicki
Jan 5, 2011·Journal of Clinical Pharmacy and Therapeutics·A C StaffordP C Tenni
Aug 29, 2009·Internal Medicine Journal·I Scott, S Jayathissa
Feb 14, 2014·Australasian Journal on Ageing·Elizabeth ManiasAlexandra Smykowsky
Aug 1, 2015·Ageing Research Reviews·Shamsher Singh, Beata Bajorek
Jan 21, 2014·Archives of Gerontology and Geriatrics·Antonio San-JoséUNKNOWN Potentially Inappropriate Prescribing in Older Patients in Spain (PIPOPS) Investigators’ project
Dec 4, 2014·Revista española de geriatría y gerontología·E Delgado SilveiraA J Cruz-Jentoft
Sep 17, 2016·La Presse médicale·Aude DesnoyerPascal Bonnabry
Sep 21, 2016·Archives of Gerontology and Geriatrics·Giancarlo Lucchetti, Alessandra L G Lucchetti
Mar 5, 2016·PloS One·Kathleen PotterChristopher Etherton-Beer
Mar 10, 2017·Journal of Evidence-based Medicine·Jie SongDan Liu
Nov 18, 2010·The Annals of Pharmacotherapy·Hedva Barenholtz LevyCatherine Christen
Jun 1, 2013·Nursing and Midwifery Studies·Tania Hammond, Anne Wilson
Dec 17, 2015·Therapeutic Advances in Drug Safety·Doron GarfinkelGulistan Bahat
Aug 1, 2012·Therapeutic Advances in Drug Safety·Tobias Dreischulte, Bruce Guthrie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.